Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Can AngloGold Ashanti Finish 2025 With Strong Free Cash Flow Growth?
Can AngloGold Ashanti Finish 2025 With Strong Free Cash Flow Growth?

AngloGold Ashanti plc AU delivered a solid 185% surge in the free cash flow in the first nine months of 2025 to $1.86 billion. This includes a record free cash flow of $920 million in the third

RR's Operating Expenses Rising: Can It Manage While Scaling?
RR's Operating Expenses Rising: Can It Manage While Scaling?

Richtech Robotics Inc. RR is battling rising operating expenses that are overshadowing growth. As of the nine months ended June 30, 2025, RR’s total operating expenses surged a whopping 150.8% year

Fluor Streamlines Portfolio With $122M Zhuhai Yard Sale
Fluor Streamlines Portfolio With $122M Zhuhai Yard Sale

Fluor Corporation FLR has taken another step in reshaping its portfolio. On Friday, the company announced an agreement to divest its stake in the Zhuhai fabrication yard in China’s Guangdong

Is KMB's Powering Care Strategy Building a Competitive Edge Into 2026?
Is KMB's Powering Care Strategy Building a Competitive Edge Into 2026?

Kimberly-Clark Corporation's KMB Powering Care strategy is steadily reshaping the company’s competitive position, reinforcing its ambition to become an industry-leading personal care powerhouse

RKLB, ASTS, TDG: Insiders are Selling These 3 Space Stocks
RKLB, ASTS, TDG: Insiders are Selling These 3 Space Stocks

Some of the most talked-about space stocks among retail investors have seen recent bouts of insider selling. Below, we’ll detail the selling surrounding Rocket Lab (NASDAQ: RKLB) and AST

BD and Penn Institute Ink Collaboration to Advance Immunotherapy
BD and Penn Institute Ink Collaboration to Advance Immunotherapy

Becton, Dickinson and Company BDX, popularly known as BD, recently announced a collaboration with the Institute for Immunology and Immune Health (I3H) at the University of Pennsylvania to develop a

Roblox Stock Down 38% in 3 Months: Buy the Dip or Sell More?
Roblox Stock Down 38% in 3 Months: Buy the Dip or Sell More?

Roblox Corporation RBLX has seen a sharp 38% decline over the past three months compared with the industry’s fall of 11.1%. However, in the same time frame, the S&P 500 has gained 3.3%.RBLX stock

Target's Shrink Normalization Emerges as Key Margin Stabilizer
Target's Shrink Normalization Emerges as Key Margin Stabilizer

Target Corporation’s TGT ongoing shrink normalization is shaping up as one of the most visible contributors to near-term margin stabilization, even as top-line trends remain pressured. After

How Goldman Is Scaling AI to Transform Its Business Operations
How Goldman Is Scaling AI to Transform Its Business Operations

The Goldman Sachs Group (GS) is executing a firmwide artificial intelligence (AI) transformation that spans trading, investment banking, asset management, and internal productivity, with a clear

All You Need to Know About Banzai International, Inc. (BNZI) Rating Upgrade to Buy
All You Need to Know About Banzai International, Inc. (BNZI) Rating Upgrade to Buy

Banzai International, Inc. (BNZI) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates

What Makes Unitil (UTL) a New Buy Stock
What Makes Unitil (UTL) a New Buy Stock

Unitil (UTL) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the

All You Need to Know About GE (GE) Rating Upgrade to Buy
All You Need to Know About GE (GE) Rating Upgrade to Buy

Investors might want to bet on GE Aerospace (GE), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock

Kinross Gold (KGC) is a Great Momentum Stock: Should You Buy?
Kinross Gold (KGC) is a Great Momentum Stock: Should You Buy?

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Micron (MU) Is Up 10.28% in One Week: What You Should Know
Micron (MU) Is Up 10.28% in One Week: What You Should Know

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

Heico (HEI) Upgraded to Buy: Here's Why
Heico (HEI) Upgraded to Buy: Here's Why

Heico Corporation (HEI) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of

EyePoint (EYPT) Is Up 9.01% in One Week: What You Should Know
EyePoint (EYPT) Is Up 9.01% in One Week: What You Should Know

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Agnico Eagle Mines (AEM) Is Up 3.53% in One Week: What You Should Know
Agnico Eagle Mines (AEM) Is Up 3.53% in One Week: What You Should Know

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

Rio Tinto (RIO) Is Up 3.52% in One Week: What You Should Know
Rio Tinto (RIO) Is Up 3.52% in One Week: What You Should Know

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

Keros Therapeutics (KROS) Upgraded to Strong Buy: Here's Why
Keros Therapeutics (KROS) Upgraded to Strong Buy: Here's Why

Keros Therapeutics, Inc. (KROS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful

Jabil (JBL) Is Up 1.91% in One Week: What You Should Know
Jabil (JBL) Is Up 1.91% in One Week: What You Should Know

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Genpact (G) Upgraded to Buy: Here's Why
Genpact (G) Upgraded to Buy: Here's Why

Genpact (G) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most

Fox (FOXA) is a Great Momentum Stock: Should You Buy?
Fox (FOXA) is a Great Momentum Stock: Should You Buy?

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

Gain Therapeutics (GANX) Upgraded to Buy: Here's Why
Gain Therapeutics (GANX) Upgraded to Buy: Here's Why

Gain Therapeutics, Inc. (GANX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces

What Makes Southern Copper (SCCO) a Strong Momentum Stock: Buy Now?
What Makes Southern Copper (SCCO) a Strong Momentum Stock: Buy Now?

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

What Makes Huron Consulting (HURN) a New Buy Stock
What Makes Huron Consulting (HURN) a New Buy Stock

Investors might want to bet on Huron Consulting (HURN), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one